InvestorsHub Logo

midastouch017

10/19/17 12:33 PM

#7365 RE: Scott999 #7357

In apropos orphan drug status and price
impact (or rather lack thereof):

RDHL : RedHill's upamostat an Orphan
Drug in U.S. for pancreatic cancer
11:44 am, Thu, Oct. 19, 2017

Look at RDHL share price!

same=same

Scott999

10/19/17 4:36 PM

#7376 RE: Scott999 #7357

Wow a gain of 3.45% today. Not far off from the average that study saw with orphan drug designation at 3.37%.